Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL
Recorded on September 3, 2019
Join Dr. Miller as he speaks with Dr. Frederick Locke from Moffitt Cancer Center in Tampa, FL on the future of CAR T-cell therapy. In this episode, Dr. Locke discusses new indications for treatment, including off-the-shelf CAR T-cells, earlier lines of therapy, allogeneic treatment options, the necessity for preparative regimens, suicide genes, dual antigen binding, and so much more. Listen in today!
Frederick L. Locke, MD
Research Director and Medical Director, Immune Cell Therapy Program
Department of Blood and Marrow Transplant and Cellular Immunotherapy
Co-Leader Immunology Program
Moffitt Cancer Center
Podcast: Play in new window | Download (Duration: 30:50 — 28.2MB)
This podcast episode is supported by Allogene Therapeutics, Inc.